Drug intelligence / Profile preview

Signature Tattoo Numbing Cream

Development stage
Unknown
Lead developer
Tattoo Numbing Cream
Modality
Small Molecules
Administration
Topical
01

Overview

**Signature Tattoo Numbing Cream** is a fixed-dose topical anesthetic product developed and sold by Tattoo Numbing Cream for temporary reduction of pain associated with tattooing and other cosmetic skin procedures. The manufacturer lists lidocaine 5%, prilocaine 5%, and epinephrine 1% as active ingredients. Lidocaine and prilocaine are local anesthetics that reversibly inhibit voltage-gated sodium channels in peripheral nerves, reducing nociceptive signal transmission; epinephrine provides local vasoconstriction through adrenergic receptor activation. The product is applied to intact skin before tattooing. FDA stated in a March 25, 2024 warning letter that this product was marketed in the United States as an external analgesic and was an unapproved new drug and misbranded product under the cited federal requirements. ([tattoonumbingcream.com](https://www.tattoonumbingcream.com/en-au/pages/ingredients))

Brand names
Signature Tattoo Numbing Cream
Other names
XL Signature
02

Targets

NaV (Voltage-gated sodium channels)ADRA2A (α2A)ADRA1A (α1A)

Beyond the preview

Go deeper on Signature Tattoo Numbing Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signature Tattoo Numbing Cream.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call